| Getting your Trinity Audio player ready... |
Estimated reading time: 2 minutes
In a tragic and rare medical case, a 58-year-old American woman has died from iatrogenic Creutzfeldt-Jakob disease (iCJD), a fatal neurodegenerative disorder caused by prions—misfolded proteins that induce abnormal folding of normal proteins in the brain. Remarkably, the disease lay dormant for nearly five decades after she received contaminated human growth hormone (hGH) treatments during childhood.
Background: The Hidden Danger in Hormone Treatments
Between the 1960s and 1980s, approximately 7,700 patients in the United States were treated with cadaver-derived hGH to address growth deficiencies. Unfortunately, some of these hormone batches were contaminated with prions, leading to cases of iCJD. The National Hormone Pituitary Program (NHPP) ceased the distribution of cadaveric hGH in 1985 after the link to prion diseases became evident.
The Patient’s Journey
The woman began experiencing neurological symptoms, including tremors and balance issues, nearly 50 years after her initial treatment. Her condition rapidly deteriorated, leading to urinary incontinence, difficulty speaking, and abnormal breathing. Hospitalization followed, during which she entered a coma and subsequently passed away. Post-mortem analyses confirmed the presence of prions in her brain tissue, affirming the diagnosis of iCJD.
Implications for Medical Practice
This case underscores the critical importance of stringent screening and sterilization processes in medical treatments, especially those involving biological materials. While the use of cadaver-derived hGH has been discontinued, the incident serves as a cautionary tale about the long-term risks associated with medical interventions and the necessity for ongoing vigilance in medical practices.
Understanding Prion Diseases
Prion diseases are a group of progressive neurodegenerative disorders affecting both humans and animals. They are characterized by long incubation periods, rapid progression once symptoms appear, and are invariably fatal. In humans, prion diseases include Creutzfeldt-Jakob disease, variant CJD, Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia, and kuru.
These diseases are particularly insidious due to their resistance to standard sterilization procedures and the absence of effective treatments. Research continues in the quest to understand prion propagation and to develop therapeutic strategies.
Sources: